Table 2 Biomarker staining by IHC and prognosis in breast cancer subtypes
From: Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Marker | Measurement | Good prognosis | Breast cancer subtype |
|---|---|---|---|
CD8 | Presence/absence | Presence | TN |
PD-L1 | >5Â % membrane staining | Presence | TN |
HER2 | 1+, 2+, 3+ | 1+ | HER2+ |
FOXP3 | Low/High (above and below median) | Low | HR+ |